東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Linked to FindBook

Google Book

Amazon

博客來

Data Analytics and Decision Making : = Evaluating Risk and Burden Associated with Infectious Respiratory Diseases.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Data Analytics and Decision Making :/
Reminder of title:	Evaluating Risk and Burden Associated with Infectious Respiratory Diseases.
Author:	Mele, Jessica A.
Description:	1 online resource (174 pages)
Notes:	Source: Dissertations Abstracts International, Volume: 84-06, Section: B.
Contained By:	Dissertations Abstracts International84-06B.
Subject:	Infections. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30167937click for full text (PQDT)
ISBN:	9798358417625

Data Analytics and Decision Making : = Evaluating Risk and Burden Associated with Infectious Respiratory Diseases.
Mele, Jessica A.

Data Analytics and Decision Making :Evaluating Risk and Burden Associated with Infectious Respiratory Diseases. - 1 online resource (174 pages)

Source: Dissertations Abstracts International, Volume: 84-06, Section: B.

Thesis (Ph.D.)--North Carolina State University, 2022.

Includes bibliographical references

Infectious respiratory diseases cause substantial burden on healthcare systems in the United States each year. In recent years, two of the most notable infectious respiratory diseases have been pneumonia and COVID-19. Recent studies suggest that pneumonia causes 1.5 million unique hospitalizations in the United States each year whereby COVID-19 is estimated to have caused 4.6 million hospitalizations nationally since it first emerged in 2020. In addition to the increased risk of severe disease and mortality, pneumonia and COVID-19 both incur substantial healthcareassociated costs. Understanding risk factors and disease characteristics remain critical components to improving health outcomes and reducing overall burden associated with these two diseases.This work explores the use of data analytics to develop tools to overcome modern challenges surrounding computational modeling and big data in healthcare with the intention to provide interpretable solutions to inform public health. The proposed models are developed to be used as tools to improve population health and facilitate intervention design to reduce severe outcomes for pneumonia and COVID-19. This work proposes new ideas and developments to guide public health policy and draws insights that result from applying these methods to real-world data.The ideas presented in this work expand upon current literature surrounding infectious respiratory disease risk, prevention, and prevalence, and provides tools to: (i) identify at-risk populations; (ii) recommend targeted intervention policies; and (iii) evaluate and understand disease burden. First, risk will be explored via the development of three predictive models to understand and evaluate 30-day risk factors for pneumonia hospitalization at the individual, community, and provider levels. Next, data-driven models will be employed to provide recommendations for targeted intervention policies to reduce hospitalizations and healthcare-associated costs. Lastly, disease progression models will be developed to inform population susceptibility, understand historical risk, and evaluate mitigation tactics associated with COVID-19.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9798358417625Subjects--Topical Terms:

1621997
Infections.
Index Terms--Genre/Form:

542853
Electronic books.

Data Analytics and Decision Making : = Evaluating Risk and Burden Associated with Infectious Respiratory Diseases.
LDR:03444nmm a2200325K 4500 001 2354528
005 20230414084821.5
006 m o d
007 cr mn ---uuuuu
008 241011s2022 xx obm 000 0 eng d
020 $a 9798358417625
035 $a (MiAaPQ)AAI30167937
035 $a (MiAaPQ)NCState_Univ18402039958
035 $a AAI30167937
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Mele, Jessica A. $3 3694883
245 1 0 $a Data Analytics and Decision Making : $b Evaluating Risk and Burden Associated with Infectious Respiratory Diseases.
264 0 $c 2022
300 $a 1 online resource (174 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 84-06, Section: B.
500 $a Advisor: Chi, Min; Ozaltin, Osman; Swann, Julie.
502 $a Thesis (Ph.D.)--North Carolina State University, 2022.
504 $a Includes bibliographical references
520 $a Infectious respiratory diseases cause substantial burden on healthcare systems in the United States each year. In recent years, two of the most notable infectious respiratory diseases have been pneumonia and COVID-19. Recent studies suggest that pneumonia causes 1.5 million unique hospitalizations in the United States each year whereby COVID-19 is estimated to have caused 4.6 million hospitalizations nationally since it first emerged in 2020. In addition to the increased risk of severe disease and mortality, pneumonia and COVID-19 both incur substantial healthcareassociated costs. Understanding risk factors and disease characteristics remain critical components to improving health outcomes and reducing overall burden associated with these two diseases.This work explores the use of data analytics to develop tools to overcome modern challenges surrounding computational modeling and big data in healthcare with the intention to provide interpretable solutions to inform public health. The proposed models are developed to be used as tools to improve population health and facilitate intervention design to reduce severe outcomes for pneumonia and COVID-19. This work proposes new ideas and developments to guide public health policy and draws insights that result from applying these methods to real-world data.The ideas presented in this work expand upon current literature surrounding infectious respiratory disease risk, prevention, and prevalence, and provides tools to: (i) identify at-risk populations; (ii) recommend targeted intervention policies; and (iii) evaluate and understand disease burden. First, risk will be explored via the development of three predictive models to understand and evaluate 30-day risk factors for pneumonia hospitalization at the individual, community, and provider levels. Next, data-driven models will be employed to provide recommendations for targeted intervention policies to reduce hospitalizations and healthcare-associated costs. Lastly, disease progression models will be developed to inform population susceptibility, understand historical risk, and evaluate mitigation tactics associated with COVID-19.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Infections. $3 1621997
650 4 $a Pneumonia. $3 871060
650 4 $a Algorithms. $3 536374
650 4 $a Frailty. $3 3690432
650 4 $a Disease. $3 705846
650 4 $a Decision making. $3 517204
650 4 $a Aging. $3 543123
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0493
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a North Carolina State University. $3 1018772
773 0 $t Dissertations Abstracts International $g 84-06B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30167937 $z click for full text (PQDT)